Dr Marzieh Amirmostofian

Research Associate

School of Pharmacy and Biomedical Science

College of Health


Year Citation
2025 Abid, F., Kim, S., Savaliya, B., Cesari, L., Amirmostofian, M., Abdella, S., . . . Garg, S. (2025). Targeting Acne: Development of Monensin-Loaded Nanostructured Lipid Carriers.. International journal of nanomedicine, 2025(20), 2181-2204.
DOI Scopus3 WoS3 Europe PMC1
2024 Youssef, S. H., Ganesan, R., Amirmostofian, M., Kim, S., Polara, R., Afinjuomo, F., . . . Garg, S. (2024). Printing a Cure: A Tailored Solution for Localized Drug Delivery in Liver Cancer Treatment.. International journal of pharmaceutics, 651(123790), 123790.
DOI Scopus7 WoS6 Europe PMC6
2023 Abid, F., Savaliya, B., Parikh, A., Kim, S., Amirmostofian, M., Cesari, L., . . . Garg, S. (2023). Nanotechnology and narasin: a powerful combination against acne.. Nanoscale, 15(33), 13728-13739.
DOI Scopus8 WoS7 Europe PMC5
2023 Amirmostofian, M., Akbari, F., Hashemzaei, M., Safaeinejad, F., Tabrizian, K., Arbab, H., . . . Shahraki, J. (2023). Hormetic effects of curcumin on oxidative stress injury induced by trivalent arsenic in isolated rat hepatocytes. Avicenna Journal of Phytomedicine, 13(6), 641-650.
DOI Scopus4 WoS3 Europe PMC3
2023 Meakin, A. S., Amirmostofian, M., Darby, J. R., Holman, S. L., Morrison, J. L., & Wiese, M. D. (2023). Characterisation of cytochrome P450 isoenzyme activity in sheep liver and placental microsomes. Placenta, 131, 82-89.
DOI Scopus3 WoS3 Europe PMC2
2017 Nazari, P., Bazi, A., Ayatollahi, S. A., Dolati, H., Mahdavi, S. M., Rafighdoost, L., & Amirmostofian, M. (2017). Synthesis and evaluation of the antimicrobial activity of spiro-4H-pyran derivatives on some gram positive and gram negative bacteria. Iranian Journal of Pharmaceutical Research, 16(3), 943-952.
Scopus26 WoS26 Europe PMC11
2017 Entezari Heravi, Y., Sereshti, H., Saboury, A. A., Ghasemi, J., Amirmostofian, M., & Supuran, C. T. (2017). 3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole–benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein. Journal of Enzyme Inhibition and Medicinal Chemistry, 32(1), 688-700.
DOI Scopus23 WoS21 Europe PMC11
2015 Amirmostofian, M., Kobarfard, F., Reihanfard, H., Mashayekhi, V., & Zarghi, A. (2015). Design, synthesis and cytotoxicity evaluationof new 1,2-diaryl-4, 5, 6, 7-tetrahydro-1h-benzo[d] imidazolesas tubulin inhibitors. Iranian Journal of Pharmaceutical Research, 14(1), 59-65.
Scopus2 WoS2 Europe PMC1
2013 Amirmostofian, M., Jaktaji, J. P., Soleimani, Z., Tabib, K., Tanbakosazan, F., Omrani, M., & Kobarfard, F. (2013). Synthesis and Molecular-cellular Mechanistic Study of Pyridine Derivative of Dacarbazine. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 12(3), 255-265.
WoS10 Europe PMC7
2009 Pourahmad, J., Amirmostofian, M., Kobarfard, F., & Shahraki, J. (2009). Biological reactive intermediates that mediate dacarbazine cytotoxicity. Cancer Chemotherapy and Pharmacology, 65(1), 89-96.
DOI Scopus61 WoS55 Europe PMC41

Year Citation
2021 Rajkumar, R., Robinson, J., Amirmostofian, M., Kahn, M. S., Mackenzie, L., Roberts, M. S., . . . Roberts, D. (2021). Prescribing implications of measured concentrations of apixaban in a geriatric inpatient population. In AUSTRALASIAN JOURNAL ON AGEING Vol. 40 (pp. 26). WILEY.

Connect With Me

External Profiles

Other Links